SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 130.27 |
| Enterprise Value ($M) | 95.05 |
| Book Value ($M) | 63.60 |
| Book Value / Share | 1.06 |
| Price / Book | 2.05 |
| NCAV ($M) | 63.13 |
| NCAV / Share | 1.05 |
| Price / NCAV | 2.06 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -0.73 |
| Return on Assets (ROA) | -0.41 |
| Return on Equity (ROE) | -0.51 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 6.49 |
| Current Ratio | 6.49 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 92.73 |
| Assets | 93.20 |
| Liabilities | 29.60 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | -60.12 |
| Net Income | -55.85 |
| Earnings Per Share Basic And Diluted | n/a |
| Earnings Per Share Diluted | n/a |
| Earnings Per Share Basic | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | -43.21 |
| Cash from Investing | -44.92 |
| Cash from Financing | -0.17 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G/A | Perceptive Advisors Llc | 8.20 | -47.44 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K/A (Amendment No. 1) | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 119,190 | 469,953 | 25.36 | |
| 259,434 | 998,176 | 25.99 | |
| 288,217 | 1,198,849 | 24.04 | |
| 308,702 | 1,098,979 | 28.09 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| AIMD – Ainos, Inc. | AKAN – Akanda Corp. |
| AKBA – Akebia Therapeutics, Inc. | ALGS – Aligos Therapeutics, Inc. |
| ALTS – ALT5 Sigma Corporation |
Financial data and stock pages provided by
Fintel.io